Australis Capital Archives

StaffOctober 18, 2022

The Daily Hit is a recap of cannabis business news for Oct. 18, 2022. ON THE SITE Flower One Files for Canadian Bankruptcy, Plans to Go Private After the markets closed on Monday, Flower One Holdings (CSE: FONE) (OTC: FLOOF) announced that it and its Canadian subsidiaries obtained an Initial Order of the Supreme Court of […]

Debra BorchardtOctober 18, 2022

Company clings to 2022 timeline.

Debra BorchardtSeptember 23, 2022

Australis says it will begin harvesting in October in New York.

StaffAugust 3, 2022

Australis Capital Inc. (CSE:AUSA) (OTCQB: AUSAF) also known as Audacious reported its unaudited results for its fiscal year ending March 31, 2022 on Tuesday. Australis said that revenues increased by over 1,200% to nearly $9.5 million. the company attributed the increase to a full year of ALPS revenue consolidated (51% of ALPS acquired on March […]

StaffMarch 2, 2022

Long after the market closed on Tuesday, Australis Capital Inc. also knowns as Audacious (CSE: AUSA) (OTC: AUSAF) announced that it had filed its financials and management discussion and analysis for the three-month period ending December 31, 2021, its fiscal third quarter of fiscal 2022 (the year ending March 31, 2022). Audacious reported that it had […]

StaffJanuary 12, 2022

Australis Capital Inc. (OTC: AUASF) also known as Audacious has entered into a definitive agreement with Golden Triangle Health (GTH) on a strategic partnership that marks the company’s first foray into the Asian market. GTH is a majority-owned subsidiary of Thai public company NRF instant PCL with a market capitalization of C$440 million. To start, […]

Debra BorchardtDecember 8, 2021

This interview was conducted with Terry Booth, CEO of Audacious in October and has been edited for clarity. Terry Booth is one of the OG’s of legal cannabis as a founder of Aurora Cannabis in 2006. His next chapter begins at Audacious Brands, which was renamed from Australis. However, his initial entry into the company […]

StaffNovember 23, 2021

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) also known as Audacious, has delivered its financials and management discussion and analysis for its fiscal second quarter of fiscal 2022 (the year ending March 31, 2022), the period ending September 30, 2021. Australis reported total revenues increased 2,068% year over year to $2.3 million and increased 31% from $1.73 […]

Debra BorchardtJune 22, 2021

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced that it is changing its name to Audacious Brands. The company’s ticker symbol will remain AUSA on the CSE and AUSAF on the OTC. The company said it will consolidate its brands under the new Audacious banner and intends to launch additional product lines under the new […]

Kaitlin DomangueFebruary 19, 2020

It’s time for your Daily Hit of cannabis financial news for February 19th, 2020. On the Site Cannabis Sustainability: Minimize Wastewater Drought and water shortages are an expensive reality in some of the best cannabis-growing regions. As a result, water conservation practices help reduce water waste and overall operations costs, particularly for commercial grows. Use […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Australis Capital

The Daily Hit: October 18, 2022

Audacious Ready for New York (Even if NY Isn’t Ready)

Australis Cuts Cash Burn, Moves Forward in New York

Audacious Outlines Northeast Strategy As Revenues Rise

Australis Trims Losses, Sees Revenues Rise

Audacious Is Selling CBD Hemp Seeds In Asian Partnership

Audacious CEO Terry Booth Says He’s In M&A Mode

Australis Capital Reports Rising Revenue, Gives Guidance For Third Quarter

Australis Capital Becomes Audacious Brands

The Daily Hit: February 19th, 2020

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox